rs61744696

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The ENST00000371757.7(KCNT1):​c.2210C>T​(p.Thr737Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0149 in 1,529,262 control chromosomes in the GnomAD database, including 212 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T737T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.012 ( 22 hom., cov: 33)
Exomes 𝑓: 0.015 ( 190 hom. )

Consequence

KCNT1
ENST00000371757.7 missense

Scores

3
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.69
Variant links:
Genes affected
KCNT1 (HGNC:18865): (potassium sodium-activated channel subfamily T member 1) Potassium channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a sodium-activated potassium channel subunit which is thought to function in ion conductance and developmental signaling pathways. Mutations in this gene cause the early-onset epileptic disorders, malignant migrating partial seizures of infancy and autosomal dominant nocturnal frontal lobe epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 9-135772916-C-T is Benign according to our data. Variant chr9-135772916-C-T is described in ClinVar as [Benign]. Clinvar id is 129356.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-135772916-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.012 (1826/152294) while in subpopulation NFE AF= 0.0173 (1175/68024). AF 95% confidence interval is 0.0165. There are 22 homozygotes in gnomad4. There are 886 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1826 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNT1NM_020822.3 linkuse as main transcriptc.2210C>T p.Thr737Met missense_variant 19/31 ENST00000371757.7 NP_065873.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNT1ENST00000371757.7 linkuse as main transcriptc.2210C>T p.Thr737Met missense_variant 19/311 NM_020822.3 ENSP00000360822 A2Q5JUK3-3

Frequencies

GnomAD3 genomes
AF:
0.0120
AC:
1826
AN:
152176
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00297
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0109
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0276
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0173
Gnomad OTH
AF:
0.0124
GnomAD3 exomes
AF:
0.0123
AC:
1673
AN:
136438
Hom.:
14
AF XY:
0.0121
AC XY:
891
AN XY:
73924
show subpopulations
Gnomad AFR exome
AF:
0.00319
Gnomad AMR exome
AF:
0.00909
Gnomad ASJ exome
AF:
0.0122
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00130
Gnomad FIN exome
AF:
0.0283
Gnomad NFE exome
AF:
0.0175
Gnomad OTH exome
AF:
0.0130
GnomAD4 exome
AF:
0.0152
AC:
20987
AN:
1376968
Hom.:
190
Cov.:
31
AF XY:
0.0148
AC XY:
10060
AN XY:
678806
show subpopulations
Gnomad4 AFR exome
AF:
0.00217
Gnomad4 AMR exome
AF:
0.0101
Gnomad4 ASJ exome
AF:
0.0109
Gnomad4 EAS exome
AF:
0.0000559
Gnomad4 SAS exome
AF:
0.00126
Gnomad4 FIN exome
AF:
0.0269
Gnomad4 NFE exome
AF:
0.0170
Gnomad4 OTH exome
AF:
0.0141
GnomAD4 genome
AF:
0.0120
AC:
1826
AN:
152294
Hom.:
22
Cov.:
33
AF XY:
0.0119
AC XY:
886
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.00296
Gnomad4 AMR
AF:
0.0108
Gnomad4 ASJ
AF:
0.00894
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.0276
Gnomad4 NFE
AF:
0.0173
Gnomad4 OTH
AF:
0.0123
Alfa
AF:
0.0141
Hom.:
28
Bravo
AF:
0.0112
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0161
AC:
62
ESP6500AA
AF:
0.00410
AC:
18
ESP6500EA
AF:
0.0153
AC:
131
ExAC
AF:
0.00814
AC:
959
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 30, 2015- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxJan 07, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Developmental and epileptic encephalopathy, 14;C3554306:Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 05, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Developmental and epileptic encephalopathy, 14 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Autosomal dominant nocturnal frontal lobe epilepsy 5 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.073
.;.;.;.;.;.;.;.;T;.
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.63
D
LIST_S2
Uncertain
0.87
D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0040
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.44
T
MutationAssessor
Benign
1.9
.;.;.;.;.;.;.;.;L;.
MutationTaster
Benign
0.94
D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.1
.;.;N;.;.;.;.;.;N;N
REVEL
Benign
0.23
Sift
Benign
0.082
.;.;T;.;.;.;.;.;T;T
Sift4G
Benign
0.097
T;T;T;T;T;T;T;T;T;T
Polyphen
0.11
.;.;.;.;.;.;.;.;B;.
Vest4
0.35
MPC
0.67
ClinPred
0.0068
T
GERP RS
3.0
Varity_R
0.061
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.24
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.24
Position offset: -5

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61744696; hg19: chr9-138664762; API